Opnurasib

Opnurasib (JDQ-443) is an orally available and selective and potent covalent KRAS G12C inhibitor with antitumor activity for the study of advanced non-small cell lung cancer.

Product Specifications

CAS Number

2653994-08-0

Stability

≥ 2 years

Purity

>98% (HPLC)

Weight

526.03

Molecular Formula

C29H28ClN7O

Notes

Research use only, not for human use.

Receptor

Kras

Available Sizes

More Discoveries

Explore Other Products

Browse additional items from our catalog

NBP1-77083MFV450 0.1 mL

Rabbit Polyclonal FRMPD2 Antibody [mFluor Violet 450 SE]

View Details

K3517301 3x 1.0 µg

Nudt11 sgRNA CRISPR Lentivector set (Mouse)

View Details

PO54452M2 100 µg

Her2/ERBB2 Protein, Canine, Recombinant (His Tag)

View Details

orb1177276 100 µg

SOX4 Antibody

View Details

NBP2-89946AF594 0.1 mL

Rabbit Monoclonal CTHRC1 Antibody (062) [Alexa Fluor 594]

View Details

GTR15137725 1 Vial

Lentiviral mouse Ror1 shRNA (UAS) - Lentiviral mouse Ror1 shRNA (UAS, RFP) plasmid

View Details